At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
ViE-21device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study of Asahi ViE Dialyzer in Canada (AVID)
In Brief
A clinical study evaluating ViE-21 for Kidney Failure, Chronic. Completed, enrolled 17 participants.
Detailed Summary
The purpose of the study is to obtain performance data on the Asahi ViE-21 dialyzer (ViE-21) .
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Failure, Chronic
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 2014
Enrollment StartNov 2014
Primary CompletionNov 2015
TodayJul 2026
First PostedNov 17, 2014
Enrollment StartNov 24, 2014
Primary CompletionNov 6, 2015
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.6 years ago
Interventions
ViE-21device
The subjects will be undergone three times KUF measurement sessions and three times blood sampling sessions during study period.